Sunnyvale, CA, United States of America

Anastasia Kadina

This inventor holds 2 USPTO granted patents and 2 published patent applications. Top assignee: Synthego Corporation. Active years: 2024.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Anastasia Kadina. Retrieved from https://idiyas.com/inventor/anastasia-kadina

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 2 

% Patents Active = 100.0

Average Co-Inventor Count = 6.0

ph-index = 1


Company Filing History:


Years Active: 2024

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Innovations of Anastasia Kadina

Introduction

Anastasia Kadina is a prominent inventor based in Sunnyvale, CA. She has made significant contributions to the field of biotechnology, particularly in the development of CRISPR technology. With a total of 2 patents, her work is paving the way for advancements in genetic engineering.

Latest Patents

Anastasia's latest patents include "Stabilized CRISPR complexes" and "Systems and methods for modulating CRISPR activity." The first patent provides polynucleotides and CRISPR effector proteins that are covalently bound together in a CRISPR complex. This innovation allows for modifications that can enhance the efficacy of target binding and cleavage. The second patent focuses on polynucleotides designed to bind to CRISPR effector proteins, enabling the tuning of their activity through various modifications.

Career Highlights

Anastasia is currently employed at Synthego Corporation, where she continues to push the boundaries of CRISPR technology. Her work is instrumental in developing tools that can be used for precise genetic modifications, which have vast implications in medicine and agriculture.

Collaborations

Anastasia collaborates with talented individuals such as Reed Kelso and Jared Carlson-Stevermer. These partnerships enhance her research and contribute to the innovative environment at Synthego Corporation.

Conclusion

Anastasia Kadina is a trailblazer in the field of biotechnology, with her patents significantly impacting the future of genetic engineering. Her contributions to CRISPR technology are vital for ongoing advancements in the industry.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…